J8565 Gefitinib - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Gefitinib

Brand Name:

Iressa

Strength:

250 mg

HCPCS:

J8565

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Tyrosine Kinase Inhibitor

Minor Drug Class:

EGFR

Oral (Y/N):

Yes

FDA Approval Year:

2015

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2005

CMS Discontinuation Date:

Status:

In Use